Tsuzukibashi O, Takada K, Saito M, Kimura C, Yoshikawa T, Makimura M, Hirasawa M
Department of Laboratory Medicine for Dentistry, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, Japan.
J Periodontal Res. 2008 Oct;43(5):544-8. doi: 10.1111/j.1600-0765.2007.01074.x. Epub 2008 Jul 4.
Conventional selective media have been used for the selection of Aggregatibacter (Actinobacillus) actinomycetemcomitans in clinical samples. The proportion of A. actinomycetemcomitans grown on the selective media in vitro may not reflect the true counts in vivo because of the low selectivity. A novel selective medium, designated AASM, was developed for the isolation of A. actinomycetemcomitans.
AASM was prepared by adding of 200 microg/mL of vancomycin and 10 U/mL of bacitracin to AAGM, which contains dextrose, sodium bicarbonate, trypticase soy, yeast extract and agar. Clinical efficacy was evaluated by the recovery, on AASM, of A. actinomycetemcomitans from subgingival samples of 44 periodontally healthy subjects and 76 patients with chronic periodontitis.
All serotypes (a-f) of A. actinomycetemcomitans strains grew well, and the average growth recovery of A. actinomycetemcomitans on AASM medium was 94.4% (80.0-109.7%) of that on AAGM. The exclusive rate of other bacteria was 99.9% in clinical samples cultured on AASM. A. actinomycetemcomitans was not detected in periodontally healthy persons but was detected in 25 (32.9%) patients with chronic periodontitis. The predominant serotype was c, detected in 11 subjects.
The new selective medium, AASM, was highly selective for A. actinomycetemcomitans, eliminated possible false-positive results and was useful for the isolation of A. actinomycetemcomitans from clinical samples.
传统的选择性培养基已用于临床样本中伴放线聚集杆菌(放线杆菌属)的筛选。由于选择性较低,在体外选择性培养基上生长的伴放线聚集杆菌比例可能无法反映体内的真实数量。一种新型选择性培养基,命名为AASM,被开发用于分离伴放线聚集杆菌。
AASM是通过向含有葡萄糖、碳酸氢钠、胰蛋白酶大豆、酵母提取物和琼脂的AAGM中添加200μg/mL的万古霉素和10U/mL的杆菌肽制备而成。通过从44名牙周健康受试者和76名慢性牙周炎患者的龈下样本中在AASM上回收伴放线聚集杆菌来评估临床疗效。
伴放线聚集杆菌菌株的所有血清型(a - f)生长良好,伴放线聚集杆菌在AASM培养基上的平均生长回收率为其在AAGM上的94.4%(80.0 - 109.7%)。在AASM上培养的临床样本中其他细菌的排除率为99.9%。在牙周健康者中未检测到伴放线聚集杆菌,但在25名(32.9%)慢性牙周炎患者中检测到。主要血清型为c型,在11名受试者中检测到。
新型选择性培养基AASM对伴放线聚集杆菌具有高度选择性,消除了可能的假阳性结果,有助于从临床样本中分离伴放线聚集杆菌。